Loading…

Design of Chitosan Nanocapsules with Compritol 888 ATO® for Imiquimod Transdermal Administration. Evaluation of Their Skin Absorption by Raman Microscopy

Purpose Design imiquimod-loaded chitosan nanocapsules for transdermal delivery and evaluate the depth of imiquimod transdermal absorption as well as the kinetics of this absorption using Raman Microscopy, an innovative strategy to evaluate transdermal absorption. This nanovehicle included Compritol...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical research 2020-10, Vol.37 (10), p.195-195, Article 195
Main Authors: Alvarez-Figueroa, María Javiera, Narváez-Araya, Daniela, Armijo-Escalona, Nicolás, Carrasco-Flores, Eduardo A., González-Aramundiz, José Vicente
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Design imiquimod-loaded chitosan nanocapsules for transdermal delivery and evaluate the depth of imiquimod transdermal absorption as well as the kinetics of this absorption using Raman Microscopy, an innovative strategy to evaluate transdermal absorption. This nanovehicle included Compritol 888ATO®, a novel excipient for formulating nanosystems whose administration through the skin has not been studied until now. Methods Nanocapsules were made by solvent displacement method and their physicochemical properties was measured by DLS and laser-Doppler. For transdermal experiments, newborn pig skin was used. The Raman spectra were obtained using a laser excitation source at 532 nm and a 20/50X oil immersion objective. Results The designed nanocapsules, presented nanometric size (180 nm), a polydispersity index
ISSN:0724-8741
1573-904X
DOI:10.1007/s11095-020-02925-6